These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15728142)

  • 1. Disc diffusion-based screening tests for extended-spectrum beta-lactamases in Haemophilus influenzae.
    Tristram SG; Bozdogan B; Appelbaum PC
    J Antimicrob Chemother; 2005 Apr; 55(4):570-3. PubMed ID: 15728142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of altered PBPs and expression of cloned extended-spectrum beta-lactamases confers cefotaxime resistance in Haemophilus influenzae.
    Bozdogan B; Tristram S; Appelbaum PC
    J Antimicrob Chemother; 2006 Apr; 57(4):747-9. PubMed ID: 16492720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple disc diffusion method for detecting AmpC and extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae.
    Derbyshire H; Kay G; Evans K; Vaughan C; Kavuri U; Winstanley T
    J Antimicrob Chemother; 2009 Mar; 63(3):497-501. PubMed ID: 19155228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
    Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cloned inhibitor-resistant TEM beta-lactamases on the susceptibility of Haemophilus influenzae to amoxicillin/clavulanate.
    Tristram SG; Burdach JG
    J Antimicrob Chemother; 2007 Nov; 60(5):1151-4. PubMed ID: 17827143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases.
    De Gheldre Y; Avesani V; Berhin C; Delmée M; Glupczynski Y
    J Antimicrob Chemother; 2003 Oct; 52(4):591-7. PubMed ID: 12972449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae.
    Hope R; Potz NA; Warner M; Fagan EJ; Arnold E; Livermore DM
    J Antimicrob Chemother; 2007 Jan; 59(1):110-3. PubMed ID: 17090552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae.
    Matic V; Bozdogan B; Jacobs MR; Ubukata K; Appelbaum PC
    J Antimicrob Chemother; 2003 Dec; 52(6):1018-21. PubMed ID: 14585854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disc diffusion susceptibility testing of Haemophilus influenzae by NCCLS methodology using low-strength ampicillin and co-amoxiclav discs.
    Kärpänoja P; Nissinen A; Huovinen P; Sarkkinen H
    J Antimicrob Chemother; 2004 Apr; 53(4):660-3. PubMed ID: 14973151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
    Apfalter P; Assadian O; Daxböck F; Hirschl AM; Rotter ML; Makristathis A
    J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
    Pal RB; Pal P; Jain S; Kulkarni KP
    J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of N526K-substituted penicillin-binding protein 3 conferring low-level mutational resistance to β-lactam antibiotics in Haemophilus influenzae by disc diffusion testing on Mueller-Hinton agar according to EUCAST guidelines.
    Søndergaard A; Petersen MT; Fuursted K; Nørskov-Lauritsen N
    J Antimicrob Chemother; 2012 Jun; 67(6):1401-4. PubMed ID: 22389455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
    Sader HS; Jacobs MR; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):5S-12S. PubMed ID: 17292577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alarmingly decreasing rates of amoxicillin-clavulanate susceptibility among clinical isolates of Haemophilus influenzae from 2001 to 2009 in a medical center in Taiwan.
    Chung KP; Huang YT; Lee LN; Yu CJ; Lai CC; Hsueh PR
    J Infect; 2011 Feb; 62(2):185-7. PubMed ID: 21145354
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE; Slocombe B; White AR
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.